Sutro Biopharma has received $26m in a Series D financing, which will be used for the expansion of its proprietary immuno-oncology product pipeline. The company is currently using its cell-free protein synthesis technology to develop new ...
Roche and Prothena have agreed to jointly develop and commercialize new antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinson's disease (PD). Currently, PRX002 is in ...
Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...
Tags: Roche, Molecular Partners
InnaVirVax, a biopharmaceutical company, has commenced a Phase II clinical trial evaluating the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy (ART) in the course of HIV-1 infection. The ...
Baxter International has filed an amended biologics license application (BLA) to the US Food and Drug Administration (FDA) to re-start the review process for approval of HyQvia facilitated subcutaneous infusion to treat adult patients with ...
Researchers at Brigham and Women’s Hospital and Massachusetts Institute of Technology have developed a new type of nanoparticle, which can be taken orally and gets successfully absorbed through the digestive tract. The nanoparticles ...
Tags: nanoparticle, Medicine
Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
Newly developed Toyopearl AF-r Protein A HC-650F introduced by Tokyo company. Tosoh has launched its newly developed separation media Toyopearl AF-r Protein A HC-650F. The biopharmaceutical industry is growing rapidly in many developed, ...
Tags: Separation Media, Tosoh, Toyopearl
Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...
Inovio Pharmaceuticals has announced that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, demonstrating the potential for a ...
Tags: DNA Vaccine, MERS Virus
Single Cell Technology (SCT) and AB Biosciences (ABB) have entered into a collaboration to identify new therapeutic antibodies. Under the deal, SCT will use its patented platform to screen plasma cells, measure the kinetics of secreted ...
Innate Pharma has started a new program named IPH43, to develop an anti-MICA therapeutic antibody in oncology. The program is the newest to emerge from the company's discovery platform. MICA, which is highly polymorphic ligand of the NK ...
Tags: Innate Pharma, Anti-Mica Antibody
Sorrento Therapeutics, a clinical-stage biopharmaceutical company, has announced a definitive agreement to acquire US-based Concortis Biosystems. This acquisition provides Sorrento Therapeutics with a comprehensive technology platform for ...
BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...